These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11024409)

  • 41. Carvedilol and metoprolol European trial: do the results merit challenge?
    Smith KM
    Am J Health Syst Pharm; 2004 Jun; 61(12):1289-93. PubMed ID: 15259762
    [No Abstract]   [Full Text] [Related]  

  • 42. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
    Díez Manglano J
    Rev Clin Esp; 2005 Apr; 205(4):149-56. PubMed ID: 15860185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
    Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
    Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of beta-blockers on the adaptive immune system in chronic heart failure.
    Shaw SM; Coppinger T; Waywell C; Dunne L; Archer LD; Critchley WR; Yonan N; Fildes JE; Williams SG
    Cardiovasc Ther; 2009; 27(3):181-6. PubMed ID: 19689617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
    Ertl G; Nitschmann S
    Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581
    [No Abstract]   [Full Text] [Related]  

  • 47. Beta-blockers in heart failure: how far have we progressed?
    Adams KF
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):7-15. PubMed ID: 19667603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure.
    Konishi M; Haraguchi G; Kimura S; Inagaki H; Kawabata M; Hachiya H; Hirao K; Isobe M
    Circ J; 2010 Jun; 74(6):1127-34. PubMed ID: 20354334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.
    Wikstrand J; Ghali JK; Goldstein S
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):16-23. PubMed ID: 19667604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of beta-blockers on mortality in chronic heart failure.
    Hart SM
    Ann Pharmacother; 2000 Dec; 34(12):1440-51. PubMed ID: 11144703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of beta-blockers in heart failure].
    Inoko M; Nohara R
    Nihon Rinsho; 2003 May; 61(5):816-20. PubMed ID: 12755008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
    Bauman JL; Talbert RL
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
    Lin TY; Chen CY; Huang YB
    Int J Cardiol; 2017 Mar; 230():378-383. PubMed ID: 28041715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AVID and COMET.
    Liebson PR; ;
    Prev Cardiol; 2003; 6(4):218-20. PubMed ID: 14605516
    [No Abstract]   [Full Text] [Related]  

  • 56. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of beta-adrenergic blockade on survival of patients with chronic heart failure.
    Packer M
    Am J Cardiol; 1997 Dec; 80(11A):46L-54L. PubMed ID: 9412542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-blockers for heart failure.
    Cohn JN
    J Card Fail; 2003 Dec; 9(6):458. PubMed ID: 14966785
    [No Abstract]   [Full Text] [Related]  

  • 59. [The role of beta-adrenergic blocking agents in treatment of heart failure].
    Witkowska M
    Pol Arch Med Wewn; 1999 Jan; 101(1):9-14. PubMed ID: 10592722
    [No Abstract]   [Full Text] [Related]  

  • 60. Selective or nonselective beta-adrenergic blockade in patients with congestive heart failure.
    Metra M; Nodari S; Boldi E; Dei Cas L
    Curr Cardiol Rep; 2000 May; 2(3):252-7. PubMed ID: 10980900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.